Home › NDC Lookup › Ingredients › Pseudoephedrine Hcl › 45802-0107-52
pseudoephedrine hydrochloride Pseudoephedrine HCl 120 mg Tablet, Film Coated, Extended Release — NDC 45802-0107-52 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

pseudoephedrine hydrochloride Pseudoephedrine HCl 120 mg Tablet, Film Coated, Extended Release — NDC 45802-107-52 (Billing 45802-0107-52)

by Padagis Israel Pharmaceuticals Ltd · 10 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of pseudoephedrine hydrochloride Pseudoephedrine HCl 120 mg Tablet, Film Coated, Extended Release from Padagis Israel Pharmaceuticals Ltd, marketed since May 2014 and currently FDA-listed; retail pharmacies pay about $0.2811 per unit (NADAC). It is this product's only package size.

NDC 45802-0107-52
🏷️ FDA NDC (as labeled) 45802-107-52 billing pads the product segment with a zero
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 45802-107-52
Product NDC 45802-107
11-digit billing NDC 45802010752
NCPDP billing unit EA — each (per item)
RxCUI 1049154
UNII 6V9V2RYJ8N
Application # ANDA075153
SPL Set ID 4a4da1e6-2ad1-47f7-a9b3-7d845962ef3b
Established class (EPC) alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-05-24
Route ORAL
Dosage form TABLET, FILM COATED, EXTENDED RELEASE
Substance PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 42101020107405
GPI class Pseudoephedrine HCl ER
GCN Seq No 016937
GCN 26901
HICL code 002091
Ingredient (HICL) Pseudoephedrine Hcl
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B6
Therapeutic class — intermediate (HIC2) Drugs Affecting The Trachea And Bronchi (Cont3)
HIC3 code B6V
Therapeutic class — specific (HIC3) Decongestants, Oral
AHFS code 12:12.12.00
AHFS class Alpha- And Beta-Adrenergic Agonists
FDB label name PSEUDOEPHEDRINE ER 120 MG TAB
FDB brand name Pseudoephedrine Er
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 016937
  • GCN: 26901
  • GPI-14 (Medi-Span): 42101020107405
  • HICL (First Databank): 002091
  • AHFS class code: 12:12.12.00
  • RxCUI (RxNorm): 1049154
Why two NDCs? The FDA registers this code as 45802-107-52 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 45802-0107-52. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the alpha-Adrenergic Agonist class.

Pharmacologic class alpha-Adrenergic Agonist
Drug family (ATC) Sympathomimetics
How it works Adrenergic alpha-Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name PSEUDOEPHEDRINE ER 120 MG TAB Ingredient Pseudoephedrine Hcl
📖 What it is MedlinePlus · NLM

Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
  • It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
  • No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
  • Can I crush or chew the extended-release tablets?
📖 Read our full Pseudoephedrine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.281 $2.81 / 10 tablet
Medicaid paysCMS SDUD · 12 mo $0.4211 $4.21 / 10 tablet
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.338 $0.263
▼ Down 8% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
45802-0107-52 You're viewing this Main listing 10 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK 2014-05-24 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pseudoephedrine Hydrochloride 120 mg 62011-0306-01 STRATEGIC 10 tablets $0.274 — FDA listed save 3%
leader 12 hour nasal decongestant 120 mg 70000-0475-01 Cardinal 1 tablet $0.276 — FDA listed save 2%
Good Sense Suphedrine 12 Hour 120 mg 00113-0054-52 L. 1 tablet $0.281 — Availability likely —
sinus 12 hour 120 mg 00113-2017-60 L. 1 tablet $0.281 — Availability likely —
SudoGest 12 Hour 120 mg 00904-6754-15 Major 1 tablet $0.281 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 00904-7409-15 Major 10 tablets $0.281 — Availability likely —
good neighbor pharmacy nasal decongestant 120 mg 24385-0054-52 Amerisource 1 tablet $0.281 — Availability likely —
pseudoephedrine hydrochloride 120 mgthis 45802-0107-52 Padagis 1 tablet $0.281 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 51660-0204-21 Ohm 20 tablets $0.281 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 51660-0492-21 Ohm 20 tablets $0.281 — Availability likely —
Pseudoephedrine Hydrochloride 120 mg 70000-0601-01 CARDINAL 20 tablets $0.281 — Availability likely —
12 Hour Nasal Decongestant 120 mg 70000-0656-01 CARDINAL 10 tablets $0.281 — Availability likely —
nasal decongestant 120 mg 70677-0001-01 Strategic 10 tablets $0.281 — Availability likely —
Pseudoephedrine hydrochloride 120 mg 70677-1019-01 STRATEGIC 10 tablets $0.281 — Availability likely —
Nasal Decongestant D 120 mg 00363-3301-52 Walgreen 1 tablet — — FDA listed —
sinus pressure and congestion relief maximum strength 120 mg 11822-0650-06 Rite 1 tablet — — FDA listed —
Pseudoephedrine HCl 120 mg 21130-0158-67 Better 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 21130-0204-21 Safeway 20 tablets — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 30142-0967-20 The 20 tablets — — FDA listed —
topcare 12 hour decongestant 120 mg 36800-0054-52 Topco 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 37808-0007-69 HEB 20 tablets — — FDA listed —
Equaline 12 Hour Decongestant 120 mg 41163-0054-60 United 1 tablet — — FDA listed —
nasal decongestant 120 mg 41250-0809-52 Meijer 1 tablet — — FDA listed —
CareOne Nasal and Sinus Decongestant 120 mg 41520-0429-52 American 1 tablet — — FDA listed —
equate sinus 12 hour 120 mg 49035-0508-60 Wal-Mart 1 tablet — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50090-4629-00 A-S 10 tablets — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 50090-5554-00 A-S 10 tablets — — FDA listed —
Sudafed Sinus Congestion 12 Hour 120 mg 50580-0242-01 Kenvue 10 tablets — — FDA listed —
sinus and nasal decongestant 120 mg 51316-0616-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 53943-0204-10 DISCOUNT 10 tablets — — FDA listed —
nasal decongestant 120 mg 56062-0054-60 Publix 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 56062-0204-21 Publix 20 tablets — — FDA listed —
Pseudoephedrine HCl 120 mg 58602-0804-67 Aurohealth 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 59779-0204-21 CVS 20 tablets — — FDA listed —
12 Hour Nasal Decongestant 120 mg 59779-0703-52 CVS 1 tablet — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 63868-0143-10 Chain 10 tablets — — FDA listed —
Pseudoephedrine Hydrochloride 120 mg 68016-0204-69 Chain 10 tablets — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 68196-0204-20 SAM'S 10 tablets — — FDA listed —
Leader 12 Hour Sinus Nasal Decongestant 120 mg 70000-0735-01 Cardinal 1 tablet — — FDA listed —
Pseudoephedrine hydrochloride 120 mg 85766-0050-10 Sportpharm 10 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
May 2014
📍
2026
Currently FDA-listed
12 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color White
ShapeOval
ImprintL054
Size18 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII R12CBM0EIZ
    A natural wax derived from a Brazilian palm tree, used as a coating and polish on tablets and capsules. It creates a smooth, shiny finish that protects the medicine and improves appearance.
  • UNII O7TSZ97GEP
    A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

9 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescarnauba wax, colloidal silicon dioxide, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPadagis Israel Pharmaceuticals Ltd
Application holderL PERRIGO CO
FDA applicationANDA075153 (ANDA)
Labeler code45802
First marketedMay 2014
Product typeHuman Otc Drug
Portfolio175 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 25 words ▾

Uses • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • temporarily relieves sinus congestion and pressure

⏱️ Dosage and Administration 42 words ▾

Directions adults and children 12 years and over • take 1 tablet every 12 hours • do not take more than 2 tablets in 24 hours children under 12 years do not use this product in children under 12 years of age

⚠️ Warnings 152 words ▾

Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • trouble urinating due to an enlarged prostate gland When using this product do not exceed recommended dosage Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or occur with a fever If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 56 words ▾

Other information • each tablet contains: calcium 45 mg • store at 20-25°C (68-77°F) in a dry place • protect from light • do not use if blister unit is broken or torn • see carton end panel for lot number and expiration date • this product meets the requirements of USP Drug Release Test 3

🧪 Active Ingredient 9 words ▾

Active ingredient (in each tablet) Pseudoephedrine HCl 120 mg

🧪 Inactive Ingredients 22 words ▾

Inactive ingredients carnauba wax, colloidal silicon dioxide, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Nasal decongestant

📄 Do Not Use 55 words ▾

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

📄 Ask a Doctor Before Use If 29 words ▾

Ask a doctor before use if you have • heart disease • high blood pressure • thyroid disease • diabetes • trouble urinating due to an enlarged prostate gland

📄 When Using This Product 9 words ▾

When using this product do not exceed recommended dosage

📄 Stop Use and Ask a Doctor If 26 words ▾

Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • symptoms do not improve within 7 days or occur with a fever

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-719-9260

📄 Package Label / Principal Display Panel 43 words ▾

Principal Display Panel Compare to Sudafed ® Sinus Congestion 12 Hour active ingredient Pseudoephedrine Hydrochloride Extended Release Tablets, 120 mg Nasal Decongestant MAXIMUM STRENGTH • SINUS PRESSURE + CONGESTION 12 HOUR SINUS 10 COATED CAPLETS* *(Capsule-shaped Tablets) actual size NON-DROWSY Padagis ™ 054-rt-pseudoephedrine-hydrochloride-extended-release-tablets.jpg

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
3K
Units reimbursed last 4 qtrs
74.8K
Gross reimbursed last 4 qtrs
$31.5K
Avg / prescription
$10.62
Avg / unit
$0.4211
Latest quarter Q1 2026
856Rx
Medicaid pays / ea
$0.4211
gross reimbursed
vs
NADAC / ea
$0.2811
acquisition cost
=
Spread
+$0.1400
+50% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
97% MCO
Fee-for-service · 91 Rx Managed care · 2,876 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 5,776 units · 101 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 23,530 units · 556 per 100k residents OR Nevada: 608 units · 19.0 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 1,648 units · 14.0 per 100k residents OH Pennsylvania: 2,403 units · 18.5 per 100k residents PA New Jersey: 5,255 units · 56.6 per 100k residents NJ Massachusetts: 1,402 units · 20.0 per 100k residents MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 3,248 units · 164 per 100k residents NE Missouri: no data reported MO Kentucky: 21,534 units · 476 per 100k residents KY West Virginia: no data reported WV Virginia: 1,793 units · 20.6 per 100k residents VA Maryland: 2,118 units · 34.3 per 100k residents MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 2,508 units · 33.8 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: 361 units · 35.0 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: 222 units · 32.7 per 100k residents DC Hawaii: no data reported HI Texas: 2,424 units · 7.9 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
7.9556
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Oregon 556 /100k
2 Kentucky 476 /100k
3 Nebraska 164 /100k
4 Minnesota 101 /100k
5 New Jersey 56.6 /100k
6 Delaware 35.0 /100k
7 Maryland 34.3 /100k
8 Arizona 33.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 45802-0104-01 · Padagis 45802-0109-01 · Padagis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.